Certara
Certara is a New Jersey-based company that provides services such as clinical pharmacology, regulatory writing and decision analytics for biopharmaceutical companies.
Business Model:
Revenue: $286.1M
Employees: 501-1,000
Industries / Tags:
Detailed Certara Information
Geographic Data
Address: 100 Overlook Center
City: Princeton
State: NJ
Zip: 08540
Country: US
Financial Info
Stage:
grant
Raised Last:
$0
Raised Total:$390M
Social
Metrics
1,089,947Website Global Rank
29,166Website Monthly Traffic
Twitter Followers
Description
Certara is a New Jersey-based company that provides services such as clinical pharmacology, regulatory writing and decision analytics for biopharmaceutical companies.
Contact Phone:
+14152378272
Contact Email:
Certara went public on 12/10/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/10/2020
IPO Valuation:
$4B
Ticker Symbol:
CERT
IPO Price:
$23/share
Amount Raised:
$668M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2021 | Post-IPO Equity | $310M | 12/2020 | IPO | $668.3M |
|
9/2021 | Grant | 1 | - |
U.S. Food and Drug Administration U.S. Food and Drug Administration |
3/2021 | Post-IPO Equity | $598.6M | 11/2022 | Post-IPO Secondary | $0 |
Arsenal Capital Partners Arsenal Capital Partners Arsenal Capital Partners Arsenal Capital Partners Arsenal Capital Partners Arsenal Capital Partners |
11/2022 | Post-IPO Equity | $449M |
Arsenal Capital Partners |
7/2021 | Post-IPO Equity | $250M |
Mubadala Investment Company |
3/2021 | Post-IPO Equity | 1 | $250M |
Mubadala Mubadala Mubadala Mubadala |
9/2021 | Post-IPO Equity | $139.5M | 9/2021 | Grant | 1 | - |
U.S. Food and Drug Administration U.S. Food and Drug Administration |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 8/2021 | Pinnacle 21 | |
| 4/2018 | Analytica Laser | |
| 2/2018 | BaseCase | |
| 9/2016 | d3 Medicine | |
| 12/2015 | XenologiQ | |
| 4/2014 | Synchrogenix | |
| 8/2013 | Great Lakes Drug Development | |
| 3/2012 | Simcyp | |
| 1/2008 | Tripos International |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
